The COVID-19 pandemic highlighted the importance of timely access to clinical trial results
for public health. Despite decades-long efforts to improve results reporting for clinical
research, problems persist. 1 Trial investigators have 3 key platforms to disseminate results:
trial registries, 2 medical journals, 3 and medical conferences. These platforms vary in their
accessibility, scope, and depth. Trials presented as abstracts at conferences are limited in
word count length and audience (conference attendees). Additionally, while ClinicalTrials …